Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration

We investigated in vivo catabolism of apolipoprotein A-II (apo A-II), a major determinant of plasma HDL levels. Like apoA-I, murine apoA-II (mapoA-II) and human apoA-II (hapoA-II) were reabsorbed in the first segment of kidney proximal tubules of control and hapoA-II-transgenic mice, respectively. A...

Full description

Bibliographic Details
Main Authors: Sonia Dugué-Pujol, Xavier Rousset, Danielle Château, Danièle Pastier, Christophe Klein, Jeannine Demeurie, Charlotte Cywiner-Golenzer, Michèle Chabert, Pierre Verroust, Jean Chambaz, François-Patrick Châtelet, Athina-Despina Kalopissis
Format: Article
Language:English
Published: Elsevier 2007-10-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520424605
_version_ 1818920460864192512
author Sonia Dugué-Pujol
Xavier Rousset
Danielle Château
Danièle Pastier
Christophe Klein
Jeannine Demeurie
Charlotte Cywiner-Golenzer
Michèle Chabert
Pierre Verroust
Jean Chambaz
François-Patrick Châtelet
Athina-Despina Kalopissis
author_facet Sonia Dugué-Pujol
Xavier Rousset
Danielle Château
Danièle Pastier
Christophe Klein
Jeannine Demeurie
Charlotte Cywiner-Golenzer
Michèle Chabert
Pierre Verroust
Jean Chambaz
François-Patrick Châtelet
Athina-Despina Kalopissis
author_sort Sonia Dugué-Pujol
collection DOAJ
description We investigated in vivo catabolism of apolipoprotein A-II (apo A-II), a major determinant of plasma HDL levels. Like apoA-I, murine apoA-II (mapoA-II) and human apoA-II (hapoA-II) were reabsorbed in the first segment of kidney proximal tubules of control and hapoA-II-transgenic mice, respectively. ApoA-II colocalized in brush border membranes with cubilin and megalin (the apoA-I receptor and coreceptor, respectively), with mapoA-I in intracellular vesicles of tubular epithelial cells, and was targeted to lysosomes, suggestive of degradation. By use of three transgenic lines with plasma hapoA-II concentrations ranging from normal to three times higher, we established an association between plasma concentration and renal catabolism of hapoA-II. HapoA-II was rapidly internalized in yolk sac epithelial cells expressing high levels of cubilin and megalin, colocalized with cubilin and megalin on the cell surface, and effectively competed with apoA-I for uptake, which was inhibitable by anti-cubilin antibodies. Kidney cortical cells that only express megalin internalized LDL but not apoA-II, apoA-I, or HDL, suggesting that megalin is not an apoA-II receptor. We show that apoA-II is efficiently reabsorbed in kidney proximal tubules in relation to its plasma concentration.
first_indexed 2024-12-20T01:22:07Z
format Article
id doaj.art-07e229707e2444f58477b2dbc9d2309b
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-20T01:22:07Z
publishDate 2007-10-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-07e229707e2444f58477b2dbc9d2309b2022-12-21T19:58:23ZengElsevierJournal of Lipid Research0022-22752007-10-01481021512161Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentrationSonia Dugué-Pujol0Xavier Rousset1Danielle Château2Danièle Pastier3Christophe Klein4Jeannine Demeurie5Charlotte Cywiner-Golenzer6Michèle Chabert7Pierre Verroust8Jean Chambaz9François-Patrick Châtelet10Athina-Despina Kalopissis11Institut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, France; Ecole Pratique des Hautes Etudes, Laboratoire de Pharmacologie Cellulaire et Moléculaire, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U538, CHU Saint Antoine, Paris, F-75012, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, France; Ecole Pratique des Hautes Etudes, Laboratoire de Pharmacologie Cellulaire et Moléculaire, Paris, F-75006, FranceInstitut National de la Santé et de la Recherche Médicale, U538, CHU Saint Antoine, Paris, F-75012, FranceInstitut National de la Santé et de la Recherche Médicale, U872, Equipe 6, Paris, F-75006 France; Université Pierre et Marie Curie-Paris 6, UMR S 872, Equipe 6, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Equipe 6, Paris, F-75006, FranceWe investigated in vivo catabolism of apolipoprotein A-II (apo A-II), a major determinant of plasma HDL levels. Like apoA-I, murine apoA-II (mapoA-II) and human apoA-II (hapoA-II) were reabsorbed in the first segment of kidney proximal tubules of control and hapoA-II-transgenic mice, respectively. ApoA-II colocalized in brush border membranes with cubilin and megalin (the apoA-I receptor and coreceptor, respectively), with mapoA-I in intracellular vesicles of tubular epithelial cells, and was targeted to lysosomes, suggestive of degradation. By use of three transgenic lines with plasma hapoA-II concentrations ranging from normal to three times higher, we established an association between plasma concentration and renal catabolism of hapoA-II. HapoA-II was rapidly internalized in yolk sac epithelial cells expressing high levels of cubilin and megalin, colocalized with cubilin and megalin on the cell surface, and effectively competed with apoA-I for uptake, which was inhibitable by anti-cubilin antibodies. Kidney cortical cells that only express megalin internalized LDL but not apoA-II, apoA-I, or HDL, suggesting that megalin is not an apoA-II receptor. We show that apoA-II is efficiently reabsorbed in kidney proximal tubules in relation to its plasma concentration.http://www.sciencedirect.com/science/article/pii/S0022227520424605high density lipoproteincubilinmegalinproximal tubuleyolk sac cellsmouse kidney cortical cells
spellingShingle Sonia Dugué-Pujol
Xavier Rousset
Danielle Château
Danièle Pastier
Christophe Klein
Jeannine Demeurie
Charlotte Cywiner-Golenzer
Michèle Chabert
Pierre Verroust
Jean Chambaz
François-Patrick Châtelet
Athina-Despina Kalopissis
Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
Journal of Lipid Research
high density lipoprotein
cubilin
megalin
proximal tubule
yolk sac cells
mouse kidney cortical cells
title Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
title_full Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
title_fullStr Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
title_full_unstemmed Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
title_short Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
title_sort apolipoprotein a ii is catabolized in the kidney as a function of its plasma concentration
topic high density lipoprotein
cubilin
megalin
proximal tubule
yolk sac cells
mouse kidney cortical cells
url http://www.sciencedirect.com/science/article/pii/S0022227520424605
work_keys_str_mv AT soniaduguepujol apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT xavierrousset apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT daniellechateau apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT danielepastier apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT christopheklein apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT jeanninedemeurie apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT charlottecywinergolenzer apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT michelechabert apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT pierreverroust apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT jeanchambaz apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT francoispatrickchatelet apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration
AT athinadespinakalopissis apolipoproteinaiiiscatabolizedinthekidneyasafunctionofitsplasmaconcentration